News archive

Latest News from the Partnership

2020.04.21 | News from the management

Nordic EMBL Partnership awarded NordForsk funding

Grant awarded as part of Nordic Research Infrastructure Hubs call

LRRK2, DANi-011A, iPSC line generated by Sendai virus reprogramming. A) iPSCs stain positive for Alkaline phosphatase. B) Expression of pluripotent markers OCT4 and NANOG. C) DNA sequencing confirms the LRRK2 G2019S variant. D) Reprogrammed iPSCs no longer contain Sendai viruses. Credit: Denham group

2020.04.16 | Publication, Knowledge exchange

New pluripotent stem cell line generated from a Parkinson’s disease patient is aimed at studying PD mechanisms and as a drug-screening platform

Denham group at DANDRITE and colleague researchers have developed a new stem cell line (DANi-011A) from a Parkinson’s disease (PD) patient carrying a LRRK2 p.G2019S mutation that is identified in inherited and sporadic cases of PD. The established cell line enables in vitro modelling of PD and the development of potential treatment strategies for…

2020.04.07 | People

Coronavirus outbreak

The partnership nodes are committed to providing a safe work environment for their staff. New measures and activities are taken into action by the Nordic EMBL Partnership in relation to the COVID-19 outbreak.